Skip to main content
. 2023 Nov 2;45(2):281–308. doi: 10.1210/endrev/bnad032

Figure 2.

Figure 2.

COVID-19 and the liver. (A) Mechanisms by which COVID-19 might cause or worsen hepatic steatosis. (B) Mechanisms by which COVID-19 might increase hepatic endogenous glucose production. Abbreviations: CA, catecholamines; ER, endoplasmic reticulum; FFA, free fatty acids; GLU, glucose; GP73, Golgi protein 73; IHTG, intrahepatic triglyceride; INS/IGF, insulin/insulin-like growth factor; IRF-1, interferon regulatory factor 1; OAA, oxaloacetate; PEP, phosphoenolpyruvate; PEPCK, phosphoenolpyruvate carboxykinase; PYR, pyruvate; ROS, reactive oxygen species.